[Risks of beta-blockers and calcium inhibitors in amyloid cardiopathy].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000686:Amyloidosis / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers
Le risque des bêta-bloqueurs et des inhibiteurs calciques dans la cardiopathie amyloïde.